The Medication Paper Final Draft “Byvalson”
paper must be a minimum of seven pages, not including your title or reference pages. You should include at least five recent references (published within the last five years), and the paper must be presented in APA format (see rough draft requirements in week 6).
The paper must include the following content information:
Make sure you explain the special considerations that your chosen drug has on the unique populations/client groups listed below. Special considerations should include absorption, clearance/elimination, distribution, metabolism half-life, loading dose, route of drug administration, and steady state.
Pediatric patients are not little adults. There are special pharmacokinetic and pharmacodynamics variations in this patient group. Their reaction to medication can be very unpredictable. Accurate dosing is the key due to their limited body mass.
Geriatric patients have altered pharmacokinetic and pharmacodynamics responses to medication. The process of aging and disease will change how the body responds to drug therapy. Memory limitations and increased sensitivity to drug therapy may cause unique problems with this population.
Patients With Renal Dysfunction
Many medications are excreted through the renal glands or metabolized and excreted renally. Dosage adjustment is the key in this population. Many agents may cause nephrotoxicity.
Patients With Liver Dysfunction
Liver disease produces alterations in the physiology of the drugs’ pharmacokinetics in the body. Special attention should be given to all drugs used in this client population
Obese patients have alterations in their pharmacokinetic and pharmacodynamic response to medication. Many comorbidities and altered nutritional status can be seen as responses to taking these medications. Accurate dosing is paramount.
Pregnancy and lactation can be challenging. Concerns of effects to the unborn fetus must be considered. Will treating the mother harm the unborn fetus or nursing infant?
Hi there! Click one of our representatives below and we will get back to you as soon as possible.